+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Compound heterozygosity for mutations in PAX6 in a patient with complex brain anomaly, neonatal diabetes mellitus, and microophthalmia

Compound heterozygosity for mutations in PAX6 in a patient with complex brain anomaly, neonatal diabetes mellitus, and microophthalmia

American Journal of Medical Genetics. Part a 149a(11): 2543-2546

We report on a patient with trisomy 21, microophthalmia, neonatal diabetes mellitus, hypopituitarism, and a complex structural brain anomaly who was a member of a large bilineal family with eye anomalies. The patient inherited a different mutation in PAX6 from each parent and is the only known living and second reported patient with compound heterozygosity for mutations in PAX6. PAX6 is a transcription factor involved in eye and brain development and has roles in pancreatic and pituitary development. Clinical evaluation of the propositus and his parents demonstrated the effects of mutations of differing severity in multiple individuals.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 052269086

Download citation: RISBibTeXText

PMID: 19876904

DOI: 10.1002/ajmg.a.33081

Related references

Malformations of the brain in two fetuses with a compound heterozygosity for two PAX6 mutations. Folia Neuropathologica 47(4): 372-382, 2010

Compound heterozygosity for Fp subunit mutations causes complex II deficiency in a patient with encephalomyopathy. American Journal of Human Genetics 65(4): A427, 1999

Compound heterozygosity for two MSH6 mutations in a patient with early onset of HNPCC-associated cancers, but without hematological malignancy and brain tumor. European Journal of Human Genetics 14(5): 561-566, 2006

A new compound heterozygosis for inactivating mutations in the glucokinase gene as cause of permanent neonatal diabetes mellitus (PNDM) in double-first cousins. Diabetology and Metabolic Syndrome 7: 101, 2015

Compound heterozygous mutations of the SBDS gene in a patient with Shwachman-Diamond syndrome, type 1 diabetes mellitus and osteoporosis. Pancreatology 6(6): 549-554, 2006

Early-Onset Central Diabetes Insipidus due to Compound Heterozygosity for AVP Mutations. Hormone Research in Paediatrics 85(4): 283-287, 2017

Compound heterozygosity of novel insulin receptor mutations in a patient with leprechaunism. Diabetologia 40(SUPPL 1): A164, 1997

Compound heterozygosity for two new TERT mutations in a patient with aplastic anemia. Pediatric Blood and Cancer 55(3): 550-553, 2010

Compound heterozygosity for ARS component B mutations in a Dutch patient with mal de Meleda. British Journal of Dermatology 160(4): 878-880, 2009

Compound heterozygosity for 2 novel TMEM16F mutations in a patient with Scott syndrome. Blood 117(16): 4399-4400, 2011

Compound heterozygosity for MSH6 mutations in a pediatric lymphoma patient. Journal of Pediatric Hematology/Oncology 31(2): 113-115, 2009

Lethal neonatal and severe late infantile forms of carnitine palmitoyltransferase II deficiency associated with compound heterozygosity for different protein truncation mutations. Journal of Pediatrics 141(5): 734-736, 2002

Compound heterozygosity for two novel mutations in the erythrocyte protein 4.2 gene causing spherocytosis in a Caucasian patient. British Journal of Haematology 152(6): 780-783, 2011

Identification of the mutations in the parents of a patient with a putative compound heterozygosity for acute intermittent porphyria. Journal of Inherited Metabolic Disease 13(5): 684-686, 1990

Compound heterozygosity for two GHR missense mutations in a patient affected by Laron Syndrome: a case report. Italian Journal of Pediatrics 43(1): 94, 2018